{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T02:25:50Z","timestamp":1781144750392,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T00:00:00Z","timestamp":1737244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81600015"],"award-info":[{"award-number":["81600015"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regenerative Therapy"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.reth.2025.01.015","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T21:31:08Z","timestamp":1743111068000},"page":"177-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Optimal dose of bone marrow mesenchymal stem cell transplantation for experimental ulcerative colitis"],"prefix":"10.1016","volume":"29","author":[{"given":"Xiaoyun","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingzhi","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangsheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reth.2025.01.015_bib1","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.3748\/wjg.14.3937","article-title":"Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies","volume":"14","author":"Lakatos","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.reth.2025.01.015_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.reth.2025.01.015_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nature00870","article-title":"Pluripotency of mesenchymal stem cells derived from adult marrow","volume":"418","author":"Jiang","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.reth.2025.01.015_bib4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jcp.21200","article-title":"Adult mesenchymal stem cells for tissue engineering versus regenerative medicine","volume":"213","author":"Caplan","year":"2007","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.reth.2025.01.015_bib5","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1007\/s10620-012-2290-5","article-title":"Systemic infusion of bone marrowderived mesenchymal stem cells for treatment of experimental colitis in mice","volume":"57","author":"He","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.reth.2025.01.015_bib6","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/CIRCULATIONAHA.105.575118","article-title":"Intracoronary bone marrow cell transfer after myocardial infarction","volume":"113","author":"Meyer","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.reth.2025.01.015_bib7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2141.2008.07040.x","article-title":"Murine bone marrow derived stromal progenitor cells fail to prevent or treat acute graft-versus-host disease","volume":"141","author":"Badillo","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.reth.2025.01.015_bib8","doi-asserted-by":"crossref","first-page":"7761","DOI":"10.4049\/jimmunol.176.12.7761","article-title":"Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice","volume":"176","author":"Sudres","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.reth.2025.01.015_bib9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/xen.12000","article-title":"Do mesenchymal stem cells function across species barriers? Relevance for xenotransplantation","volume":"19","author":"Li","year":"2012","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.reth.2025.01.015_bib10","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/trf.12421","article-title":"Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices","volume":"54","author":"Sharma","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.reth.2025.01.015_bib11","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.imlet.2016.02.016","article-title":"In vivo immunomodulatory effects of adipose-derived mesenchymal stem cells conditioned medium in experimental autoimmune encephalomyelitis","volume":"172","author":"Yousefi","year":"2016","journal-title":"Immunol Lett"},{"key":"10.1016\/j.reth.2025.01.015_bib12","first-page":"257","article-title":"Phenotypic modulation of auto-reactive cells by insertion of tolerogenic molecules via MSC-derived exosomes","volume":"3","author":"Mokarizadeh","year":"2012","journal-title":"Vet Res Forum"},{"key":"10.1016\/j.reth.2025.01.015_bib13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13287-015-0100-7","article-title":"Donor mesenchymal stem cell-derived neural-like cells transdifferentiate into myelin-forming cells and promote axon regeneration in rat spinal cord transection","volume":"6","author":"Qiu","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.reth.2025.01.015_bib14","article-title":"Conserved dopamine neurotrophic factor-transduced mesenchymal stem cells promote axon regeneration and functional recovery of injured sciatic nerve","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.reth.2025.01.015_bib15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neulet.2014.03.023","article-title":"Mesenchymal stromal cells integrate and form longitudinally-aligned layers when delivered to injured spinal cord via a novel fibrin scaffold","volume":"569","author":"Hyatt","year":"2014","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.reth.2025.01.015_bib16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5966\/sctm.2011-0019","article-title":"Concise review: mesenchymal stem cells and translational medicine: emerging issues","volume":"1","author":"Ren","year":"2012","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.reth.2025.01.015_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.5966\/sctm.2011-0024","article-title":"Concise review: clinical translation of wound healing therapies based on mesenchymal stem cells","volume":"1","author":"Jackson","year":"2012","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.reth.2025.01.015_bib18","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1159\/000338134","article-title":"Current status of mesenchymal stem cell therapy and bone marrow transplantationin IBD","volume":"30","author":"Ricart","year":"2012","journal-title":"Dig Dis"},{"key":"10.1016\/j.reth.2025.01.015_bib19","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/CIRCULATIONAHA.105.575118","article-title":"Intracoronary bone marrow cell transfer after myocardial infarction","volume":"113","author":"Meyer","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.reth.2025.01.015_bib20","doi-asserted-by":"crossref","first-page":"7761","DOI":"10.4049\/jimmunol.176.12.7761","article-title":"Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice","volume":"176","author":"Sudres","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.reth.2025.01.015_bib21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.15283\/ijsc.2015.8.1.54","article-title":"New strategies for overcoming limitations of mesenchymal stem cell-based immune modulation","volume":"8","author":"Kim","year":"2015","journal-title":"Int J Stem Cells"},{"key":"10.1016\/j.reth.2025.01.015_bib22","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13287-015-0240-9","article-title":"The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy","volume":"6","author":"Zhang","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.reth.2025.01.015_bib23","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/trf.12421","article-title":"Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices","volume":"54","author":"Sharma","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.reth.2025.01.015_bib24","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2005-04-1496","article-title":"Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy","volume":"106","author":"Zappia","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.reth.2025.01.015_bib25","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.4049\/jimmunol.180.3.1598","article-title":"Human mesenchymal stem cells license adult CD34+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway","volume":"180","author":"Li","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.reth.2025.01.015_bib26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/14653240903502712","article-title":"Mesenchymal stromal cells inhibit graft-versus-host disease of mice in a dose-dependent manner","volume":"12","author":"Joo","year":"2010","journal-title":"Cytotherapy"},{"key":"10.1016\/j.reth.2025.01.015_bib27","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/gut.2008.168534","article-title":"Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis","volume":"58","author":"Gonzalez-Rey","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.reth.2025.01.015_bib28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00535-010-0320-7","article-title":"Myogenic lineage differentiated mesenchymal stem cells enhance recovery from dextran sulfate sodium-induced colitis in the rat","volume":"46","author":"Tanaka","year":"2011","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.reth.2025.01.015_bib29","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1159\/000369743","article-title":"Mesenchymal stem cells recruit macrophages to alleviate experimental colitis through TGF\u03b21","volume":"35","author":"Liu","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.reth.2025.01.015_bib30","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s13287-015-0254-3","article-title":"Allogeneic Guinea pig mesenchymal stem cells ameliorate neurological changes in experimental colitis","volume":"6","author":"Stavely","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.reth.2025.01.015_bib31","doi-asserted-by":"crossref","first-page":"7787","DOI":"10.4049\/jimmunol.0902318","article-title":"Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis","volume":"183","author":"Zhang","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.reth.2025.01.015_bib32","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/stem.698","article-title":"Pretreatment with interferon-\u03b3 enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis","volume":"29","author":"Duijvestein","year":"2011","journal-title":"Stem Cell"},{"key":"10.1016\/j.reth.2025.01.015_bib33","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/ibd.20382","article-title":"Subcutaneous adipose tissue-derived stem cells facilitate colonic mucosal recovery from 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in rats","volume":"14","author":"Ando","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.reth.2025.01.015_bib34","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1053\/j.gastro.2008.11.041","article-title":"Adiposederived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses","volume":"136","author":"Gonzalez","year":"2009","journal-title":"Gastroenterol"},{"key":"10.1016\/j.reth.2025.01.015_bib35","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/gutjnl-2012-302152","article-title":"Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis","volume":"62","author":"Anderson","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.reth.2025.01.015_bib36","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3727\/096368910X557245","article-title":"Human umbilical cord mesenchymal stem cells ameliorate mice trinitrobenzene sulfonic acid (TNBS)-induced colitis","volume":"20","author":"Liang","year":"2011","journal-title":"Cell Transplant"},{"key":"10.1016\/j.reth.2025.01.015_bib37","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1053\/j.gastro.2013.08.033","article-title":"Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2","volume":"145","author":"Kim","year":"2013","journal-title":"Gastroenterol"},{"key":"10.1016\/j.reth.2025.01.015_bib38","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/path.2535","article-title":"Enhancing epithelial engraftment of rat mesenchymal stem cells restores epithelial barrier integrity","volume":"218","author":"Yabana","year":"2009","journal-title":"J Pathol"},{"key":"10.1016\/j.reth.2025.01.015_bib39","doi-asserted-by":"crossref","first-page":"92","DOI":"10.15283\/ijsc.2013.6.2.92","article-title":"The possible role of mesenchymal stem cells therapy in the repair of experimentally induced colitis in male albino rats","volume":"6","author":"Fawzy","year":"2013","journal-title":"Int J Stem Cells"},{"key":"10.1016\/j.reth.2025.01.015_bib40","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/gut.2008.168534","article-title":"Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis","volume":"58","author":"Gonzalez-Rey E","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.reth.2025.01.015_bib41","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1007\/s10620-012-2290-5","article-title":"Systemic infusion of bone marrowderived mesenchymal stem cells for treatment of experimental colitis in mice","volume":"57","author":"He","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.reth.2025.01.015_bib42","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.3748\/wjg.v19.i29.4702","article-title":"Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses","volume":"19","author":"Chen","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.reth.2025.01.015_bib43","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1053\/j.gastro.2008.11.041","article-title":"Adipose derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses","volume":"136","author":"Gonzalez","year":"2009","journal-title":"Gastroenterol"},{"key":"10.1016\/j.reth.2025.01.015_bib44","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.lfs.2008.09.016","article-title":"Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats","volume":"83","author":"Tanaka","year":"2008","journal-title":"Life Sci"},{"key":"10.1016\/j.reth.2025.01.015_bib45","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1124\/jpet.108.137083","article-title":"Topical implantation of mesenchymal stem cells has beneficial effects on healing of experimental colitis in rats","volume":"326","author":"Hayashi","year":"2008","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.reth.2025.01.015_bib46","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.exphem.2007.11.002","article-title":"Transplantable marrow osteoprogenitors engraft in discrete saturable sites in the marrow microenvironment","volume":"36","author":"Marino","year":"2008","journal-title":"Exp Hematol"},{"key":"10.1016\/j.reth.2025.01.015_bib47","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1073\/pnas.98.4.1757","article-title":"Distinct role of gp130 activation in promoting self-renewal divisions by mitogenically stimulated murine hematopoietic stem cells","volume":"98","author":"Audet","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.reth.2025.01.015_bib48","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/bit.10399","article-title":"Common and distinct features of cytokine effects on hematopoietic stem and progenitor cells revealed by dose\u2013response surface analysis","volume":"80","author":"Audet","year":"2002","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.reth.2025.01.015_bib49","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1634\/stemcells.20-2-119","article-title":"Ligand\/receptor signaling threshold (LIST) model accounts for gp130- mediated embryonic stem cell self-renewal responses to LIF and HIL-6","volume":"20","author":"Viswanathan","year":"2002","journal-title":"Stem Cell"}],"container-title":["Regenerative Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320425000161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320425000161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T04:34:39Z","timestamp":1763699679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352320425000161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":49,"alternative-id":["S2352320425000161"],"URL":"https:\/\/doi.org\/10.1016\/j.reth.2025.01.015","relation":{},"ISSN":["2352-3204"],"issn-type":[{"value":"2352-3204","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimal dose of bone marrow mesenchymal stem cell transplantation for experimental ulcerative colitis","name":"articletitle","label":"Article Title"},{"value":"Regenerative Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reth.2025.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier BV on behalf of The Japanese Society for Regenerative Medicine.","name":"copyright","label":"Copyright"}]}}